Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

CMS Proposes Greater Access To Preventive Services In 2011 Fee Schedule

This article was originally published in The Gray Sheet

  • News

Executive Summary

Medicare beneficiaries could have their preventive services customized to individual risk factors under a calendar 2011 physician fee schedule proposal released June 25

You may also be interested in...



Preventive Service Regs Could Give Screening Tools A Boost

Preventive services including colonoscopies, mammograms and diabetes screenings may become more accessible under a federal government plan announced July 14

Preventive Service Regs Could Give Screening Tools A Boost

Preventive services including colonoscopies, mammograms and diabetes screenings may become more accessible under a federal government plan announced July 14

Outpatient Payment Draft Supports Preventive Health Care Screening Tests

Medicare beneficiaries would no longer have to pay coinsurance for certain colorectal cancer screening tests under CMS' 2011 Outpatient Prospective Payment System proposed rule

Table

View full table

Related Content

Medtech Insight

Topics

Tags:
Medical Device
Latest Headlines

UK MHRA Updates Assistive Tech And Borderline Regulations

EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions

UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

See All
UsernamePublicRestriction

Register

MT029081

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By